ANKRD11-CHMP1A Fusion FISH Probe
The ANKRD11-CHMP1A Fusion FISH Probe is used to confirm a fusion of the ANKRD11 and CHMP1A genes. The fusion of the ANKRD11 and CHMP1A genes has been associated with Uterine Corpus Endometrial Carcinoma, and Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ANKRD11-CHMP1A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-CHMP1A-20-AQAQ | 20 (40 μL) | 200 μL |
|
CHMP1A Gene Summary
This gene encodes a member of the CHMP/Chmp family of proteins which are involved in multivesicular body sorting of proteins to the interiors of lysosomes. The initial prediction of the protein sequence encoded by this gene suggested that the encoded protein was a metallopeptidase. The nomenclature has been updated recently to reflect the correct biological function of this encoded protein. Several transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Gene Name: Charged Multivesicular Body Protein 1A
Chromosome: CHR16: 89710843 -89724129
Locus: 16q24.3
ANKRD11 Gene Summary
This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]
Gene Name: Ankyrin Repeat Domain 11
Chromosome: CHR16: 89334034 -89556969
Locus: 16q24.3
Gene Diseases
The ANKRD11 CHMP1A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|